BETA vs CRNX
Comparison between BETA Technologies Inc - Class A (BETA, Company) and Crinetics Pharmaceuticals Inc (CRNX, Company).
BETA is from the Industrials sector, while CRNX is from the Healthcare sector.
BETA vs CRNX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
BETA vs CRNX - Historical Returns
Returns include dividend reinvestment.
BETA vs CRNX - Annual Returns (2018 - 2026)
Returns include dividend reinvestment.
| Year | BETA | CRNX |
|---|---|---|
| 2026 | -37.38% | -29.55% |
| 2025 | -21.64% | -9.70% |
| 2024 | N/A | +44.48% |
| 2023 | N/A | +96.57% |
| 2022 | N/A | -35.36% |
| 2021 | N/A | +103.66% |
| 2020 | N/A | -44.45% |
| 2019 | N/A | -14.40% |
| 2018 | N/A | +22.36% |
BETA vs CRNX Drawdown Comparison
The maximum drawdown for BETA was -63.07%, occurring on Mar 30, 2026. This drawdown has not yet recovered.
The maximum drawdown for CRNX was -68.70%, occurring on Mar 16, 2020. Recovery took 1326 trading sessions.
The current BETA drawdown is -53.49%. The current CRNX drawdown is -45.76%.
| Rank | BETA | CRNX |
|---|---|---|
| #1 | -63.07% Nov 5, 2025 - Mar 30, 2026 | -68.70% Sep 12, 2018 - Dec 19, 2023 |
| #2 | N/A | -57.88% Nov 8, 2024 - Apr 8, 2025 |
| #3 | N/A | -18.72% May 16, 2024 - Jul 11, 2024 |
| #4 | N/A | -17.60% Mar 1, 2024 - Mar 28, 2024 |
| #5 | N/A | -13.35% Jul 16, 2024 - Oct 15, 2024 |
| #6 | N/A | -12.30% Apr 11, 2024 - May 8, 2024 |
| #7 | N/A | -9.31% Aug 23, 2018 - Sep 6, 2018 |
| #8 | N/A | -8.79% Feb 9, 2024 - Feb 27, 2024 |
| #9 | N/A | -7.55% Jul 18, 2018 - Jul 23, 2018 |
| #10 | N/A | -6.96% Dec 19, 2023 - Jan 9, 2024 |
| #11 | N/A | -6.46% Oct 22, 2024 - Nov 7, 2024 |
| #12 | N/A | -6.38% Jan 9, 2024 - Feb 8, 2024 |
| #13 | N/A | -5.82% May 8, 2024 - May 16, 2024 |
| #14 | N/A | -4.49% Aug 13, 2018 - Aug 17, 2018 |
| #15 | N/A | -4.26% Feb 28, 2024 - Mar 1, 2024 |
Correlation
Correlation between BETA and CRNX is 0.74 which considered as a strong positive correlation - the stocks tend to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks